The philanthropic sector in general and the membership of the Health Research Alliance in particular, is composed of a diverse set of organizations who have contributed to advancing biomedical research by developing human capital; building knowledge and expanding scientific disciplines; supporting institutions; stimulating innovation; translating discoveries into cures, therapeutics and prevention of disease; establishing product development partnerships; fostering the dissemination of information, data sharing and collaboration; and advocating for resources and policy changes. When HRA first started, most of the funding by members was traditional NIH-style grants, such as Research Grants, Career Development Awards, Fellowships, and Program Project or... read more →
New Search
If you are not happy with the results below please do another searchUnder development by the Drug and Other Therapy Development working group, this “toolkit of toolkits” will enable member organizations to more easily identify and access existing and up-to-date resources relevant to DOTD working group goals. Drug and Other Therapy Development References U.S. Food and Drug Administration - for the latest developments in regulatory policies and regulatory science. National Institute of Neurological Disorders and Stroke - resources and tools needed to advance the fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. QB3 - hub for innovation and entrepreneurship in the life sciences: a... read more →
American Institute of Biological Sciences (AIBS) Council of Member Societies and Organizations 2016 Meeting AIBS hosted a meeting Titled “The Role of Peer Review in Informed Decision-making.” The meeting tackled questions: Do we know what we need to know about peer review? Does peer review meet the needs of the modern publication system? How effectively does peer review identify the best research proposals? Is peer review properly incentivized and are reviewers being asked to evaluate the right things? Betsy Myers from Doris Duke Charitable Foundation was a panelist at this meeting. You can read her piece called "Foundations and Peer Review:... read more →
HRA Members Meeting Spring 2018 Traditional research funding mechanisms usually require a regimen of standard documents and peer review processes. At the Health Research Alliance Member Meeting in New York in March 2018, three leading organizations presented their new approaches to accelerate innovation by using novel funding mechanisms. Partnership with biotech and pharma With a focus on science management and a team of scientists and other professionals that work closely with a network of laboratories around the world, the CHDI foundation’s funding strategy is using a different approach then grants, RFPs or study section-type periodic peer reviews. CHDI Foundation is... read more →
OPEN SCIENCE FOSTERS AN ENVIRONMENT WHERE RESEARCH CAN FLOURISH -- PUSHING INNOVATION, IMPROVING HEALTH, AND SOLVING GLOBAL PROBLEMS. “An old tradition and a new technology have converged to make possible an unprecedented good…” The opening line of the Budapest Open Access Initiative declaration, the published February 14, 2002 and commenced this “Open Access” movement in science. It’s been sixteen years since the call to provide open access to publications, which SPARC defines as “free, immediate, online availability of research articles coupled with the rights to use these articles fully in the digital environment.” Since this movement started, the demand for... read more →
One of the issues that led to the formation of the Health Research Alliance many years ago was defining “best practices” in grants management. Challenges such as electronic grant applications, tracking alumni, increasing diversity, and implementing effective peer review spurred a group of funders to share challenges and experiences in attempts to solve some of the more intractable problems funders faced. Partnering in this way was so valuable to these organizations, they worked together to form the alliance that eventually became the HRA. HRA formed the Grants Administration Working Group to share attempts at addressing ongoing challenges in grantmaking. Discussions have... read more →
The philanthropic sector in general and the membership of the Health Research Alliance in particular, are composed of a diverse set of organizations who have contributed to advancing biomedical research by developing human capital; building knowledge and expanding scientific disciplines; supporting institutions; stimulating innovation; translating discoveries into cures, therapeutics and prevention of disease; establishing product development partnerships; fostering the dissemination of information, data sharing and collaboration; and, advocating for resources and policy changes. The variations in the types of funding mechanisms HRA members employ has significantly evolved along with the broader funding community. For instance, HRA has many members who fund in part or... read more →
Page
HRA members are improving and saving lives by virtue of how they fund and find research programs. From voluntary health agencies to private foundations, and operating foundations, HRA members are at the helm of innovation in biomedical and health research. HRA membership provides you with the opportunity to learn from over 100 leading nonprofit foundations on how to advance mission-critical programs, drive innovative approaches, and adopt and adapt best practices. Five Benefits of HRA Membership COMMUNITY. Biannual Members’ Meetings, educational webinars, and other events cover cutting-edge science topics and nuts & bolts advice, and more importantly, facilitate connections and... read more →
Research funding mechanisms usually require a number of standard documents (i.e., research proposal, biographical sketches, and budget) and go through a peer review process. A number of groups however, are trying new approaches to accelerate innovation and solve tough problems through novel funding mechanisms. In this session, we will hear from three organizations using funding models ranging from endowments and crowdsourcing to unique scientific gatherings and ways to connect academic research to drug discovery and clinical studies. During this session, speakers will discuss the rationale for using their approaches, key considerations when developing and implementing a certain approach, and the... read more →